MoneyWorks4Me

Ajanta Pharma - Quaterly Results

31 Jul 2026 Evaluate
The company witnessed a 23.18% growth in the revenue at Rs. 14886.70 millions for the quarter ended June 2026 as compared to Rs. 12085.60 millions during the year-ago period.A slim rise of 23.73% was recorded in the Net profit for the quarter ended June 2026 to Rs. 3154.70  millions  From Rs. 2549.70 millions.The company reported a good operating profit of 4675.20 millions compared to 3700.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 14886.70 12085.60 23.18 14886.70 12085.60 23.18 48459.20 43220.40 12.12
Other Income 708.20 406.30 74.30 708.20 406.30 74.30 2044.00 1198.70 70.52
PBIDT 4675.20 3700.30 26.35 4675.20 3700.30 26.35 14023.90 13245.90 5.87
Interest 7.60 7.30 4.11 7.60 7.30 4.11 25.90 46.00 -43.70
PBDT 4667.60 3693.00 26.39 4667.60 3693.00 26.39 13998.00 13199.90 6.05
Depreciation 433.10 403.10 7.44 433.10 403.10 7.44 1687.70 1399.30 20.61
PBT 4234.50 3289.90 28.71 4234.50 3289.90 28.71 12310.30 11800.60 4.32
TAX 1079.80 740.20 45.88 1079.80 740.20 45.88 2842.10 2631.70 7.99
Deferred Tax 63.50 32.90 93.01 63.50 32.90 93.01 76.00 51.40 47.86
PAT 3154.70 2549.70 23.73 3154.70 2549.70 23.73 9468.20 9168.90 3.26
Equity 250.70 250.70 0.00 250.70 250.70 0.00 250.70 250.70 0.00
PBIDTM(%) 31.41 30.62 2.57 31.41 30.62 2.57 28.94 30.65 -5.57
Peers
Company Name CMP
Sun Pharma. Inds. 1857.05
Dr. Reddys Labs. 1170.40
Cipla 1374.85
Lupin 2089.15
Zydus Lifesciences 1131.85
View more..